Firmonertinib (Alflutinib) mesylate is a potent, third generation EGFR inhibitor that targets both EGFR activating mutations and T790M thus leading to tumor growth inhibition. Firmonertinib (AST2818) has the potential for the research of non-small cell lung cancer (NSCLC).
Molecular Weight:
664.7
Purity:
>99.0%
CAS Number:
[2130958-55-1]
Formula:
C29H35F3N8O5S
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted
